Gene Query: MMP9

Dataset Description Geneva Score
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 326.07
RNAseq of IL-36 stimulated primary human keratinocytes 141.52
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 136.39
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 136.39
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 133.49
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 122.75
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 104.9
RNA-seq of stable and unstable section of human atherosclerotic plaques 91.76
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 90.14
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 89.74
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 89.74
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 84.26
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 83.99
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 83.99
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 76.56
Differetially expressed genes after hTR overexpression in U2OS cells 69.17
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 68.91
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 65.35
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 65.35
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 64.46
RNA-seq analysis of AML cells in response to ASLAN003 63.16
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 62.12
Ectoderm specification of H1 human embryonic stem cells 60.25
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 57.7
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 57.63
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 53.56
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 51.35
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 49.83
MARCKS and lnc-MARCKS act as inflammation regulators 49.74
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 49.13
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 47.5
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 45.87
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 45.51
Transcriptome of diurnal human blood neutrophils 43.28
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 43.23
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 43.04
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 42.57
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 39.46
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 38.77
CDK12 mediated transcriptional regulation in U2OS cells 38.72
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 38.47
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 38.1
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 37.32
Generation and functional characterization of MDSC-like cells 36.85
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 35.8
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 35.42
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 35.32
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 35.17
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 34.47
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 33.73
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 33.73
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 33.68
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 33.4
Fibroblasts in cholesteatoma activate osteoclasts. 33.05
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 33.05
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 33.01
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 32.76
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 32.23
Transcription elongation regulates genome 3D structure 32.07
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 32.07
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 31.2
Dysregulated immune system networks in war veterans with PTSD 30.06
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 28.9
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 28.47
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 28.07
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 27.99
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 27.83
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 27.8
Direct Isolation and Characterization of Human Nephron Progenitors. 27.59
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 25.6
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 25.19
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 25.05
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 25.05
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 25.03
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 24.49
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 24.37
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 24.33
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 24.23
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 23.8
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 23.78
A practical evaluation of alignment algorithms for RNA variant calling analysis 23.7
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 23.23
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 23.23
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 23.16
Transcriptome analysis of virus infected tissues 23.15
Primary human trophoblast from term placenta 23.06
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 23.06
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 22.71
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 22.69
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 22.65
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 22.54
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 22.0
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 21.86
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 21.54
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 21.54
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 21.38
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 21.28
A map of gene expression in neutrophil-like cell lines 21.25
CSL 20.93
CSL RNA-Seq on HKC and SCC cell lines 20.93
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 20.83
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 20.65
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 19.23
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 18.52
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 18.44
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 18.44
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 18.37
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 18.26
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 18.19
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 18.03
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 17.66
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 17.54
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 17.41
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 17.41
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 17.32
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 17.05
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 16.76
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 16.73
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 16.68
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 16.66
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 16.62
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 16.58
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 16.57
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 16.5
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 16.37
Transcriptomes of human monocytes after ex vivo exposure to uric acid 15.71
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 15.57
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 15.26
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 15.03
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 14.38
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 14.17
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 14.17
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 14.06
Efficient derivation of microglia-like cells from human pluripotent stem cells 14.01
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 13.96
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 13.3
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 13.07
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 13.02
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 12.41
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 12.25
Human neutrophil genome during PMA- and E. coli encounter-induced activation 12.25
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 12.2
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 12.0
RNA-seq of CD33 KO and control HSPCs 11.92
Total RNA sequencing of WT intestinal orgaonids. 11.86
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 11.7
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 11.7
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 11.67
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 11.53
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 11.37
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 11.34
Anti-inflammatory effect of indoleacrylic acid (IA) 11.12
Microglia innatly develop within cerebral organoids 11.09
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 11.08
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 11.0
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 10.96
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 10.9
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 10.8
Clinker: visualizing fusion genes detected in RNA-seq data 10.79
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 10.68
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 10.67
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 10.57
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 10.53
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 10.52
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 10.49
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 10.33
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 10.2
Genome-wide identification of cancer-specific alternative splicing in circRNA 10.19
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 10.16
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 10.04
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 9.94
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 9.92
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 9.81
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 9.67
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 9.62
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 9.48
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 9.45
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 9.45
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 9.42
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 9.26
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 9.14
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 9.09
JunB control of keratinocyte-mediated inflammation [RNA-seq] 9.09
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 9.0
The cytokine environment influence on human skin-derived T cells 8.99
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 8.9
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 8.83
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 8.83
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 8.82
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 8.4
Transcriptional dependencies in diffuse intrinsic pontine glioma 8.39
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 8.35
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 8.31
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 8.18
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 8.17
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 8.17
Hepatosplenic T cell lymphoma 8.14
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 8.14
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 8.1
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 8.09
An acquired vulnerability of drug resistant melanoma with therapeutic potential 8.0
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 8.0
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 7.99
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 7.99
SLIGRL-induced gene expression changes in NHEK cells 7.84
Intrahepatic MAIT cell gene expression revealed by RNA-seq 7.83
Leucegene: ALL sequencing 7.82
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 7.72
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 7.72
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 7.7
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 7.57
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 7.57
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 7.47
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 7.47
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 7.47
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 7.46
CD74 role in transcription regulation 7.46
CD74 role in transcription regulation [RNA-seq] 7.46
Gene expression changes associated with resistance to tagraxofusp (SL-401) 7.43
oxLDL exposed trained monocytes 7.38
Transcriptomes of oxLDL exposed trained monocytes 7.38
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 7.37
RNA-seq in endometrial stromal tumors 7.34
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 7.25
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 7.25
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.21
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.21
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 7.11
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 7.11
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 7.08
MAIT cell RNA sequencing 7.02
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 6.96
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 6.95
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 6.95
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 6.92
Transcriptomic analysis of frontal fibrosing alopecia 6.91
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 6.83
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 6.82
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 6.82
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 6.81
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 6.81
Real-time observation of light-controlled transcription in living cells 6.78
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 6.65
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.61
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 6.59
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 6.59
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.48
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 6.4
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 6.4
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 6.34
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 6.3
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 6.25
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 6.22
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 6.11
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 6.1
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 6.04
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 5.97
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.85
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 5.8
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 5.78
RNA-sequencing of formalin fixed human primary melanoma tissue 5.71
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 5.71
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 5.68
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 5.68
Transcriptome of human white and brown adipose tissue biopsies 5.62
ZIKV infection of monocytes activates inflammasome pathways 5.6
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 5.58
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 5.57
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 5.53
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 5.5
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 5.46
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 5.46
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.38
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 5.34
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 5.34
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 5.23
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 5.06
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 5.06
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 5.04
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 5.04
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 5.03
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 5.03
RNA-seq analysis to identify the genes regulated by p53-SET interplay 4.97
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 4.97
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 4.91
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 4.91
Illumina HiSeq Sequencing on Breast cancer PDX samples 4.87
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 4.82
Intron retention induced by microsatellite expansions as a disease biomarker. 4.8
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.69
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.69
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 4.67
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 4.61
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 4.61
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 4.58
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 4.53
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 4.53
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 4.43
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 4.41
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 4.37
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 4.35
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 4.35
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 4.32
Zika virus infection reprograms global transcription of host cells to allow sustained infection 4.28
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 4.24
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 4.22
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 4.2
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 4.19
Gene expression profile of human iPSC-derived nephron progenitor cells 4.1
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.09
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.06
circRNA profile in hypopharyngeal cancer 4.05
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 4.01
Epigenome regulation during epidermal lineage commitment [RNA-seq] 3.99
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.97
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 3.91
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 3.91
Aortic Valve Tissue: Stenosis vs. Sclerosis 3.9
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 3.89
RNA-Seq and expression data from human adipose tissue 3.89
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 3.88
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.88
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 3.86
Transcriptomic analyssis following EHMT1/2 inhibition 3.83
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 3.79
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 3.77
Transcriptional effect of ETV1 knockdown in melanoma cells 3.68
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 3.63
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 3.52
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 3.52
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.48
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 3.47
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 3.45
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.41
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.4
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.4
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 3.4
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 3.39
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 3.39
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.32
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.31
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.29
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.28
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 3.26
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 3.19
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.17
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 3.11
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 3.11
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 3.1
Investigate A2M treatment on human prostate cancer xenograft in mice 3.08
Investigate A2M treatment on human prostate cancer and mouse liver 3.08
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.04
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 2.99
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.99
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.99
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.96
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.9
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.9
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.9
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 2.88
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 2.88
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 2.87
RNA-seq analysis of control and Myc-induced U2OS cells 2.86
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.86
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.85
Bone marrow derived human B cells [normal proB] 2.85
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.85
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.83
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.83
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.82
The interplay between SOX4 and SMAD3 in the context of breast cancer 2.74
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 2.72
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 2.72
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 2.69
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 2.69
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 2.62
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 2.6
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 2.55
The expression profiles of GBC liver metastasis 2.54
Dynamic 3D chromosomal landscapes in acute leukemia 2.54
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.54
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.49
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.49
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.47
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.46
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.46
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.45
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.45
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.42
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 2.33
Epigenome regulation during epidermal lineage commitment 2.31
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 2.31
Human T-cell lymphoblastic lymphoma samples and control thymuses 2.31
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 2.31
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.26
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 2.25
Reprogrammed myeloid cell transcriptomes in NSCLC 2.21
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 2.12
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.11
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 2.11
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.09
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.07
RNAseq analysis of ruxolitinib treated breast cancers 2.04
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.97
RNA-sequencing of human tendon after injury 1.95
Measure transcript integrity using RNA-seq data 1.94
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.91
The DNA methylation landscape of human melanoma 1.91
The DNA methylation landscape of human melanoma [RNA-Seq] 1.91
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 1.88
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 1.85
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.83
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.83
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 1.82
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 1.81
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.77
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.76
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 1.75
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 1.7
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.68
Molecular Criteria for Defining the Naive Human Pluripotent State 1.64
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 1.63
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 1.63
Targeted enhancer activation by a subunit of the integrator complex 1.59
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.57
RNA-seq of naive and primed ES cells 1.56
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.54
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.53
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.53
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.45
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.45
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.43
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.43
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 1.42
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.4
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.4
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.38
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.38
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.38
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.36
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.28
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 1.26
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.24
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 1.22
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.22
RNA-seq of primary patient AML samples 1.21
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 1.21
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.2
Common inflammatory pathways between NEC and Crohn's disease 1.16
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.01
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.97
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.95
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.94
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.91
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.9
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.89
The Glioma-Infiltrating T Cell Receptor Repertoire 0.89
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.89
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.82
Tpl-2 and MEK small molecule inhibitors 0.81
Tpl-2 small molecule project 0.81
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 0.78
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.77
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.77
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.76
Expression patterns in chronic thromboembolic pulmonary hypertension 0.72
iPSC-Derived Cholangiocytes 0.71
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.71
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.7
Gene expression of collecting duct carcinoma of the kidney 0.69
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.68
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.6
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 0.6
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 0.57
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.57
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.57
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.51
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.51
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.42
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.42
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.4
CUREfast: Accelerating research with families 0.38
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.36
ML29755 RNA-seq data 0.31
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.28
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.28
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.27
Transcriptome Profiling of Human Primary Monocytes 0.23
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.23
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 0.16
Noncoding regions are the main source of targetable tumor-specific antigens 0.14
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 0.13
Leucegene: AML sequencing (part 6) 0.12
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.1
Electronic cigarettes 0.08
Engineering Patient-Specific Tissue Implants 0.08
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.07
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.02
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.01
Expression analysis of the TAF1 syndrome 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation